SB Financial Group reported an insider purchase by director Strausbaugh Sue Ann, who acquired 48 shares of the bank holding company's common stock on March 4, 2026. The shares were bought at $20.68 apiece, producing a total transaction value of $992.
Following the purchase, Strausbaugh's direct holdings stand at 155 shares. She also holds 2,850 shares indirectly in joint ownership with her spouse. The trade occurred against a backdrop of company-initiated share buybacks, a broader indicator of management activity in the stock, as noted in InvestingPro analysis.
Market data cited in the filing show the stock trading at $20.64 and carrying a price-to-earnings ratio of 9.39. According to InvestingPro's Fair Value assessment, SB Financial Group appears undervalued on that metric.
SB Financial Group's most recent quarterly results covered the fourth quarter of 2025. The company reported earnings per share of $0.65, narrowly exceeding analysts' expectations of $0.64. Revenue for the quarter totaled $16.58 million, reflecting the firm's performance in its core operations.
In addition to financial results, Brean Capital has resumed coverage of SB Financial Group, assigning a Buy rating and a price target of $24.00. That coverage restart followed Brean Capital's acquisition of Janney Montgomery Scott's Banking and Insurance capital markets teams, a corporate development noted in the filing disclosures.
SB Financial Group also hosted a conference call to discuss its fourth-quarter results and filed the related materials with the Securities and Exchange Commission as part of a Form 8-K. The company reported 6,227,310 common shares outstanding in its filings.
Though the director's purchase was relatively small in dollar terms, the transaction and the company's recent financial and market actions - including buybacks, an EPS beat, and renewed analyst coverage - together form the current public picture of SB Financial Group's activity in the financial markets.
What happened - Director Strausbaugh Sue Ann purchased 48 shares at $20.68 each for a total of $992 on March 4, 2026.
Context - Management share repurchases are ongoing; InvestingPro flags the stock as undervalued. The company reported Q4 2025 EPS of $0.65 on $16.58 million in revenue, slightly above estimates, and has 6,227,310 shares outstanding. Brean Capital resumed coverage with a Buy rating and $24.00 target.